PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 83 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,006 | +80.1% | 6,730 | 0.0% | 0.00% | – |
| Q2 2023 | $1,114 | -93.6% | 6,730 | -62.0% | 0.00% | – |
| Q1 2023 | $17,304 | +30.7% | 17,730 | +39.3% | 0.00% | – |
| Q4 2022 | $13,239 | -87.7% | 12,730 | -64.4% | 0.00% | – |
| Q1 2022 | $108,000 | -33.7% | 35,776 | -17.0% | 0.00% | – |
| Q4 2021 | $163,000 | -55.0% | 43,120 | -38.4% | 0.00% | – |
| Q3 2021 | $362,000 | +36100.0% | 70,055 | +23251.7% | 0.00% | – |
| Q1 2021 | $1,000 | – | 300 | +435.7% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 56 | -91.5% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 656 | +9.3% | 0.00% | – |
| Q4 2019 | $2,000 | -89.5% | 600 | -89.1% | 0.00% | – |
| Q3 2019 | $19,000 | +375.0% | 5,500 | +587.5% | 0.00% | – |
| Q2 2019 | $4,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,196,527 | $16,526,000 | 3.00% |
| BVF INC/IL | 5,328,239 | $27,547,000 | 1.08% |
| Soleus Capital Management, L.P. | 740,000 | $3,826,000 | 0.60% |
| Cutter & CO Brokerage, Inc. | 326,100 | $1,686,000 | 0.40% |
| EAM Investors, LLC | 288,459 | $1,491,000 | 0.25% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $5,316,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,551,000 | 0.11% |
| Navis Wealth Advisors, LLC | 16,000 | $83,000 | 0.06% |
| Sigma Planning Corp | 364,484 | $1,884,000 | 0.06% |
| XTX Topco Ltd | 32,650 | $169,000 | 0.06% |